These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

303 related items for PubMed ID: 11823264

  • 1. A PET study of the pathophysiology of negative symptoms in schizophrenia. Positron emission tomography.
    Potkin SG, Alva G, Fleming K, Anand R, Keator D, Carreon D, Doo M, Jin Y, Wu JC, Fallon JH.
    Am J Psychiatry; 2002 Feb; 159(2):227-37. PubMed ID: 11823264
    [Abstract] [Full Text] [Related]

  • 2. Cortical-striatal-thalamic circuits and brain glucose metabolic activity in 70 unmedicated male schizophrenic patients.
    Siegel BV, Buchsbaum MS, Bunney WE, Gottschalk LA, Haier RJ, Lohr JB, Lottenberg S, Najafi A, Nuechterlein KH, Potkin SG.
    Am J Psychiatry; 1993 Sep; 150(9):1325-36. PubMed ID: 8352343
    [Abstract] [Full Text] [Related]

  • 3. Medial prefrontal default-mode hypoactivity affecting trait physical anhedonia in schizophrenia.
    Park IH, Kim JJ, Chun J, Jung YC, Seok JH, Park HJ, Lee JD.
    Psychiatry Res; 2009 Mar 31; 171(3):155-65. PubMed ID: 19217758
    [Abstract] [Full Text] [Related]

  • 4. Mood disturbances and regional cerebral metabolic abnormalities in recently abstinent methamphetamine abusers.
    London ED, Simon SL, Berman SM, Mandelkern MA, Lichtman AM, Bramen J, Shinn AK, Miotto K, Learn J, Dong Y, Matochik JA, Kurian V, Newton T, Woods R, Rawson R, Ling W.
    Arch Gen Psychiatry; 2004 Jan 31; 61(1):73-84. PubMed ID: 14706946
    [Abstract] [Full Text] [Related]

  • 5. Regional brain glucose metabolism: correlations to biochemical measures and anxiety in patients with schizophrenia.
    Wik G, Wiesel FA.
    Psychiatry Res; 1991 Oct 31; 40(2):101-14. PubMed ID: 1722339
    [Abstract] [Full Text] [Related]

  • 6. Regional cerebral glucose metabolism in never-medicated patients with schizophrenia.
    Clark C, Kopala L, Li DK, Hurwitz T.
    Can J Psychiatry; 2001 May 31; 46(4):340-5. PubMed ID: 11387790
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Stability of resting deoxyglucose metabolic values in PET studies of schizophrenia.
    Bartlett EJ, Barouche F, Brodie JD, Wolkin A, Angrist B, Rotrosen J, Wolf AP.
    Psychiatry Res; 1991 May 31; 40(1):11-20. PubMed ID: 1946838
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Altered frontostriatal relationship in unmedicated schizophrenic patients.
    Biver F, Goldman S, Luxen A, Delvenne V, De Maertelaer V, De La Fuente J, Mendlewicz J, Lotstra F.
    Psychiatry Res; 1995 Sep 29; 61(3):161-71. PubMed ID: 8545500
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Three clinical syndromes of schizophrenia in untreated subjects: relation to brain glucose activity measured by positron emission tomography (PET).
    Kaplan RD, Szechtman H, Franco S, Szechtman B, Nahmias C, Garnett ES, List S, Cleghorn JM.
    Schizophr Res; 1993 Dec 29; 11(1):47-54. PubMed ID: 8297804
    [Abstract] [Full Text] [Related]

  • 14. Patterns of cortical activity in schizophrenia.
    Schroeder J, Buchsbaum MS, Siegel BV, Geider FJ, Haier RJ, Lohr J, Wu J, Potkin SG.
    Psychol Med; 1994 Nov 29; 24(4):947-55. PubMed ID: 7892362
    [Abstract] [Full Text] [Related]

  • 15. Positron emission tomography assessment of cerebral glucose metabolic rates in autism spectrum disorder and schizophrenia.
    Mitelman SA, Bralet MC, Mehmet Haznedar M, Hollander E, Shihabuddin L, Hazlett EA, Buchsbaum MS.
    Brain Imaging Behav; 2018 Apr 29; 12(2):532-546. PubMed ID: 28425060
    [Abstract] [Full Text] [Related]

  • 16. Regional cerebral blood flow changes and performance deficit during a sustained attention task in schizophrenia: (15) O-water positron emission tomography.
    Seok JH, Park HJ, Lee JD, Kim HS, Chun JW, Son SJ, Oh MK, Ku J, Lee H, Kim JJ.
    Psychiatry Clin Neurosci; 2012 Dec 29; 66(7):564-72. PubMed ID: 23252922
    [Abstract] [Full Text] [Related]

  • 17. [Hypofrontality and negative symptoms in schizophrenia: synthesis of anatomic and neuropsychological knowledge and ecological perspectives].
    Semkovska M, Bédard MA, Stip E.
    Encephale; 2001 Dec 29; 27(5):405-15. PubMed ID: 11760690
    [Abstract] [Full Text] [Related]

  • 18. The brain metabolic patterns of clozapine- and fluphenazine-treated patients with schizophrenia during a continuous performance task.
    Cohen RM, Nordahl TE, Semple WE, Andreason P, Litman RE, Pickar D.
    Arch Gen Psychiatry; 1997 May 29; 54(5):481-6. PubMed ID: 9152102
    [Abstract] [Full Text] [Related]

  • 19. Effect of attention on frontal distribution of delta activity and cerebral metabolic rate in schizophrenia.
    Guich SM, Buchsbaum MS, Burgwald L, Wu J, Haier R, Asarnow R, Nuechterlein K, Potkin S.
    Schizophr Res; 1989 May 29; 2(6):439-48. PubMed ID: 2487185
    [Abstract] [Full Text] [Related]

  • 20. Relative glucose metabolic rate higher in white matter in patients with schizophrenia.
    Buchsbaum MS, Buchsbaum BR, Hazlett EA, Haznedar MM, Newmark R, Tang CY, Hof PR.
    Am J Psychiatry; 2007 Jul 29; 164(7):1072-81. PubMed ID: 17606659
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.